128 related articles for article (PubMed ID: 19149853)
1. Clinical benefit of recombinant factor VIIa in management of bleeds and surgery in two brothers suffering from the Bernard-Soulier syndrome.
Tefre KL; Ingerslev J; Sørensen B
Haemophilia; 2009 Jan; 15(1):281-4. PubMed ID: 19149853
[TBL] [Abstract][Full Text] [Related]
2. Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome.
Ozelo MC; Svirin P; Larina L
Ann Hematol; 2005 Nov; 84(12):816-22. PubMed ID: 16044315
[TBL] [Abstract][Full Text] [Related]
3. Treatment of inherited platelet disorders.
Seligsohn U
Haemophilia; 2012 Jul; 18 Suppl 4():161-5. PubMed ID: 22726101
[TBL] [Abstract][Full Text] [Related]
4. [Obstetric and gynecological intervention in women with Bernard-Soulier syndrome: report of two cases].
Mitrović M; Elezović I; Miljić P; Antić D
Srp Arh Celok Lek; 2014; 142(5-6):351-5. PubMed ID: 25033594
[TBL] [Abstract][Full Text] [Related]
5. Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency.
O'Connell NM; Riddell AF; Pascoe G; Perry DJ; Lee CA
Haemophilia; 2008 Jul; 14(4):775-81. PubMed ID: 18384352
[TBL] [Abstract][Full Text] [Related]
6. Treatment of bleeding in patients with platelet disorders: is there a place for recombinant factor VIIa?
Laurian Y
Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():37-40. PubMed ID: 12214146
[TBL] [Abstract][Full Text] [Related]
7. The use of recombinant factor VIIa in children with inherited platelet function disorders.
Almeida AM; Khair K; Hann I; Liesner R
Br J Haematol; 2003 May; 121(3):477-81. PubMed ID: 12716372
[TBL] [Abstract][Full Text] [Related]
8. Congenital and acquired platelet disorders: current dilemmas and treatment strategies.
White GC
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S37-41. PubMed ID: 16427384
[TBL] [Abstract][Full Text] [Related]
9. Clinical phenotype in heterozygote and biallelic Bernard-Soulier syndrome--a case control study.
Bragadottir G; Birgisdottir ER; Gudmundsdottir BR; Hilmarsdottir B; Vidarsson B; Magnusson MK; Larsen OH; Sorensen B; Ingerslev J; Onundarson PT
Am J Hematol; 2015 Feb; 90(2):149-55. PubMed ID: 25370924
[TBL] [Abstract][Full Text] [Related]
10. Treatment of a patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa.
Peters M; Heijboer H
Thromb Haemost; 1998 Aug; 80(2):352. PubMed ID: 9716174
[No Abstract] [Full Text] [Related]
11. Complementary effect of fibrinogen and rFVIIa on clotting ex vivo in Bernard-Soulier syndrome and combined use during three deliveries.
Palsson R; Vidarsson B; Gudmundsdottir BR; Larsen OH; Ingerslev J; Sorensen B; Onundarson PT
Platelets; 2014; 25(5):357-62. PubMed ID: 23909788
[TBL] [Abstract][Full Text] [Related]
12. Management of factor VII-deficient patients undergoing joint surgeries--preliminary results of locally developed treatment regimen.
Windyga J; Zbikowski P; Ambroziak P; Baran B; Kotela I; Stefanska-Windyga E
Haemophilia; 2013 Jan; 19(1):89-93. PubMed ID: 22845882
[TBL] [Abstract][Full Text] [Related]
13. [Recombinant factor VIIa in patients with platelet function disorders or thrombocytopenia].
Zotz RB; Scharf RE
Hamostaseologie; 2007 Sep; 27(4):251-62. PubMed ID: 17938763
[TBL] [Abstract][Full Text] [Related]
14. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
[TBL] [Abstract][Full Text] [Related]
15. Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
Manning BJ; Hynes N; Courtney DF; Sultan S
Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):525-7. PubMed ID: 16099693
[TBL] [Abstract][Full Text] [Related]
16. Bernard-Soulier syndrome with severe bleeding: absent platelet glycoprotein Ib alpha due to a homozygous one-base deletion.
Li C; Pasquale DN; Roth GJ
Thromb Haemost; 1996 Nov; 76(5):670-4. PubMed ID: 8950770
[TBL] [Abstract][Full Text] [Related]
17. Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group.
Poon MC; d'Oiron R
Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S55-68. PubMed ID: 10850567
[TBL] [Abstract][Full Text] [Related]
18. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
Hennewig U; Laws HJ; Eisert S; Göbel U
Klin Padiatr; 2005; 217(6):365-70. PubMed ID: 16307424
[TBL] [Abstract][Full Text] [Related]
19. Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U; Erhardtsen E
Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
[TBL] [Abstract][Full Text] [Related]
20. Iron deficiency anemia and bleeding management in pediatric patients with Bernard-Soulier syndrome and Glanzmann Thrombasthenia: A single-institution analysis.
Lee A; Maier CL; Batsuli G
Haemophilia; 2022 Jul; 28(4):633-641. PubMed ID: 35412688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
